Silencing p21WAF1/CIP1 increased expression of the androgen receptor in prostate cancer cells, thereby stimulating expression of the viral E1A gene driven by the used androgen receptor-dependent prostate-specific promoter. The gene discussed is AR; the disease is prostate cancer.